ENGN
enGene Holdings Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$509.12M
P/E Ratio
—
EPS
$-2.25
Beta
-0.05
52W High
$12.25
52W Low
$2.65
50-Day MA
$8.36
200-Day MA
$7.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About enGene Holdings Inc. Common Stock
enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The company is headquartered in Saint-Laurent, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-127.14M |
| Operating Margin | 0.00% |
| Return on Equity | -46.10% |
| Return on Assets | -25.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.20 |
| Price-to-Book | 1.81 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -6.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $66.99M |
| Float | $26.44M |
| % Insiders | 0.09% |
| % Institutions | 98.08% |
Historical Volatility
HV 10-Day
61.10%
HV 20-Day
63.85%
HV 30-Day
88.28%
HV 60-Day
86.30%
HV Rank
67.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($23.27 target)
2
Strong Buy7
Buy1
HoldData last updated: 4/15/2026